MS. TAMAR HOWSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

IMMUNIC, INC.

Filing Date Source Excerpt
2020-04-29 Ms. Howson is currently an Independent Director at MEI Pharma, Inc., and, until recently, was an Independent Director at Organovo Holdings, Inc. and Scientus Pharma. Earlier, she was a Senior Advisor on the transaction team at JSB-Partners, providing business development support to life sciences companies.
2021-04-27 Ms. Howson is currently an Independent Director at MEI Pharma, Inc., and Cue Biopharma, Inc. and was until recently an Independent Director at Organovo Holdings, Inc. and Scientus Pharma.
2022-04-27 Ms. Howson has served as an Independent Director at various biotech companies and worked in corporate business development roles, with no mention of software or technical skills.
2023-05-01 Ms. Howson’s extensive experience in corporate and business development in the biotechnology and pharmaceutical industries qualify her to serve as a member of our board.
2024-04-23 Ms. Howson’s extensive experience in corporate and business development in the biotechnology and pharmaceutical industries qualify her to serve as a member of our board.

Data sourced from SEC filings. Last updated: 2026-02-08